Research funding

Ongoing

  • 2022 – 2025 Grant Agency of Charles University: “Novel anti - AML drugs and their role in the resistance of leukemic cells” (225001), main researcher - MSc. Fahda Ahmed)
  • 2020 – 2022 Charles University – PRIMUS: “Pharmacokinetic mechanisms of drug resistance in acute myeloid leukemia, their affecting and regulation” (PRIMUS/20/MED/010, main researcher - Assoc. Prof. Dr. Martina Čečková)
     
  • 2020 – 2023 Grant Agency of Charles University: “Evaluation of ABC transporters in acute myeloid leukemia and their interaction with novel FLT3 inhibitors as a potential promising therapeutic strategy” (205019, main researcher - Mgr. Simona Suchá)
     
  • 2020 – 2022 The Czech Science Foundation: “Study on the role of novel targeted breast and lung anticancer drugs in the phenomenon of pharmacokinetic drug resistance“ (20-20414Y, co-researcher - Assoc. Prof. Dr. Martina Čečková)
  • 2018 – 2022 Operation Programme Research, Development and Education: “Efficiency and Safety Improvement of Current Drugs and Nutraceuticals: Advanced Methods – New Challenges” (CZ.02.1.01/0.0/0.0/16_019/0000841, junior scientist - Assoc. Prof. Dr. Martina Čečková)

Past

  • 2016 – 2018 Grant Agency of Charles University: “Study of interactions of novel antiretroviral drugs with placental drug transporters” (616216/C, main researcher - Mgr. Lenka Ťupová)
  • 2015 – 2017 Grant Agency of Charles University: “Study of interactions of cyclin-dependent kinases with drug efflux transporters ABCB1, ABCG2 and ABCC1” (344315/C, main researcher - Mgr. Aleš Šorf)
  • 2013 – 2016 The Czech Science Foundation: “Interactions of antiretroviral drugs with human drug transporters in vitro in consideration of transplacental pharmacokinetics“ (GP13-31118P, main researcher - Assoc. Prof. Dr. Martina Čečková)

© Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic
Website information | Powered by Kentico